#abbvie — Public Fediverse posts

How Investors May Respond To AbbVie (ABBV) Securing EU Approval For Short-Acting Boey Aesthetic Toxin

In July 2026, Allergan Aesthetics, an AbbVie company, received European Commission approval for Boey (trenibotulinumtoxinE), a rapid-onset, short-duration…
#Europe #EU #AbbVie #Boey #EuropeanUnion #facialaesthetics
https://www.europesays.com/europe/99538/

https://www.europesays.com/uk/1095559/ AbbVie (ABBV) Wins EU Approval For Boey Frown Line Treatment In Europe #AbbVie #AllerganAesthetics #boey #EU #Europe #European #EuropeanAesthetics #SimplyWallSt #TreatmentDuration

AbbVie (ABBV) Wins EU Approval For Boey Frown Line Treatment In Europe

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
#Europe #EU #AbbVie #AllerganAesthetics #Boey #Europeanaesthetics #EuropeanUnion #SimplyWallSt #treatmentduration
https://www.europesays.com/europe/96977/

Allergan Aesthetics receives approval for Boey® , for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients

Boey® is the first and only rapid-onset and short-duration botulinum neurotoxin serotype E approved in Europe that adult…
#Europe #EU #ABBV #AbbVie #nyse-abbv #pharmaceutical-investing
https://www.europesays.com/europe/96688/

Allergan Aesthetics receives approval for Boey® , for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients https://www.byteseu.com/2203741/ #abbv #AbbVie #Europe #NyseAbbv #PharmaceuticalInvesting

Why US multinationals keep choosing Ireland. It’s not just the tax or workforce – The Irish Times

If you ask US multinationals why they choose Ireland as a base for investment, they’ll talk about the…
#NewsBeep #News #Economy #AbbVie #Alphabet #Apple #Business #feargal-orourke #GileadSciences #ida-ireland #merck #Microsoft #stryker #UK #UnitedKingdom
https://www.newsbeep.com/uk/684198/

https://www.europesays.com/ie/578158/ Why US multinationals keep choosing Ireland. It’s not just the tax or workforce – The Irish Times #AbbVie #Alphabet #Apple #Business #Economy #Éire #FeargalOrourke #GileadSciences #IDAIreland #IE #Ireland #Merck #Microsoft #Stryker

https://www.europesays.com/es/649987/ Actualidad para la innovación farmacéutica #abbvie #AstraZeneca #Business #D1 #DaiichiSankyo #Economía #Economy #ES #España #johnson&johnson #Laboratorios #roche #Spain

EU Approves Expanded Use of ABBV’s Tepkinly in Follicular Lymphoma

AbbVie ABBV announced that the European Commission (EC) approved the expanded use of Tepkinly (epcoritamab) for the relapsed or…
#Europe #EU #ABBV #AbbVie #adultpatients #AmarinCorporation #EuropeanCommission #EuropeanUnion #follicularlymphoma #R/RFL #systemictherapy #ZacksInvestmentResearch
https://www.europesays.com/europe/88824/

AbbVie Announces TEPKINLY® in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

TEPKINLY® (epcoritamab) plus lenalidomide and rituximab (R2) is the first and only bispecific-based therapy approved in Europe for…
#Europe #EU #EuropeanCommission #ABBV #AbbVie #nyse-abbv #pharmaceutical-investing
https://www.europesays.com/europe/87767/

AbbVie TEPKINLY approved in EU for follicular lymphoma

TEPKINLY® (epcoritamab) plus lenalidomide and rituximab (R2) is the first and only bispecific-based therapy approved in Europe for…
#Europe #EU #EuropeanCommission #ABBV #AbbVie #epcoritamab #follicularlymphoma #marketingauthorization #oncology #TEPKINLY
https://www.europesays.com/europe/87729/

SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease

SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or…
#NewsBeep #News #Medication #AbbVie #CA #Canada #chronicconditions #Health #Healthcareprovider #NationalPsoriasisFoundation #pediatricpatients #plaquepsoriasis #PsoriaticArthritis #sideeffects #SKYRIZI #treatment
https://www.newsbeep.com/ca/765104/

SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease

SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or…
#NewsBeep #News #Medication #AbbVie #chronicconditions #Health #Healthcareprovider #NationalPsoriasisFoundation #pediatricpatients #plaquepsoriasis #PsoriaticArthritis #sideeffects #SKYRIZI #treatment #UK #UnitedKingdom
https://www.newsbeep.com/uk/661387/

https://www.europesays.com/ie/557155/ SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease #AbbVie #ChronicConditions #Éire #Health #HealthcareProvider #IE #Ireland #Medication #NationalPsoriasisFoundation #PediatricPatients #PlaquePsoriasis #PsoriaticArthritis #SideEffects #SKYRIZI #treatment

SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease

SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #AbbVie #chronicconditions #Health #Healthcareprovider #NationalPsoriasisFoundation #pediatricpatients #plaquepsoriasis #PsoriaticArthritis #sideeffects #SKYRIZI #Treatment
https://www.newsbeep.com/us/729138/

SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease

SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #AbbVie #chronicconditions #Health #Healthcareprovider #NationalPsoriasisFoundation #pediatricpatients #plaquepsoriasis #PsoriaticArthritis #sideeffects #SKYRIZI #Treatment
https://www.newsbeep.com/us/729138/

https://www.europesays.com/uk/1053419/ SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease #AbbVie #ChronicConditions #Health #HealthcareProvider #Medication #NationalPsoriasisFoundation #PediatricPatients #PlaquePsoriasis #PsoriaticArthritis #SideEffects #SKYRIZI #treatment #UK #UnitedKingdom

64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital

Quick Read KO and ABBV anchor the portfolio at 25% each, rated Very Safe with payout ratios under…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Personalfinance #ABBV #AbbVie #Business #dividendyields #freecashflow #ModerateRisk #PersonalFinance #top10AIstocks #traditionalIRA #Verizon
https://www.newsbeep.com/us/724545/

64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital

Quick Read KO and ABBV anchor the portfolio at 25% each, rated Very Safe with payout ratios under…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Personalfinance #ABBV #AbbVie #Business #dividendyields #freecashflow #ModerateRisk #PersonalFinance #top10AIstocks #traditionalIRA #Verizon
https://www.newsbeep.com/us/724545/

64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital

Quick Read KO and ABBV anchor the portfolio at 25% each, rated Very Safe with payout ratios under…
#NewsBeep #News #Personalfinance #ABBV #AbbVie #AU #Australia #Business #dividendyields #Finance #freecashflow #ModerateRisk #PersonalFinance #top10AIstocks #traditionalIRA #Verizon
https://www.newsbeep.com/au/758541/

64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital

Quick Read KO and ABBV anchor the portfolio at 25% each, rated Very Safe with payout ratios under…
#NewsBeep #News #Personalfinance #ABBV #AbbVie #AU #Australia #Business #dividendyields #Finance #freecashflow #ModerateRisk #PersonalFinance #top10AIstocks #traditionalIRA #Verizon
https://www.newsbeep.com/au/758541/

https://www.europesays.com/ie/552739/ 64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital #ABBV #AbbVie #Business #DividendYields #Éire #FreeCashFlow #IE #Ireland #ModerateRisk #PersonalFinance #PersonalFinance #Top10AIStocks #TraditionalIRA #Verizon

AbbVie Gets EU Nod for Skyrizi in Pediatric Plaque Psoriasis

AbbVie ABBV announced that the European Commission (EC) has approved its blockbuster immunology drug, Skyrizi (risankizumab), for treating children…
#Europe #EU #AbbVie #approvedindications #chronicHCVinfection #EuropeanCommission #EuropeanUnion #HCVinfection #operationalbasis #plaquepsoriasis #SKYRIZI #ZacksInvestmentResearch
https://www.europesays.com/europe/78381/

AbbVie Announces European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus Infection

MAVIRET® (glecaprevir/pibrentasvir) is now approved in the European Union for the treatment of acute hepatitis C virus (HCV)…
#Europe #EU #EuropeanCommission #AbbVie #antiviral #chronicHCVinfection #HCVinfection #hepatitisC #MAVIRET #TheEuropeanUnion
https://www.europesays.com/europe/77996/

AbbVie wins EU approval for SKYRIZI in children

SKYRIZI® (risankizumab) expands its indication for children and adolescents six years of age and older with moderate to…
#Europe #EU #EuropeanCommission #ABBV #AbbVie #biopharma #EuropeanCommissionapproval #pediatricplaquepsoriasis #Phase3 #risankizumab #SKYRIZI
https://www.europesays.com/europe/77471/

AbbVie Announces European Commission Approval of MAVIRET® for People with Acute Hepatitis C Virus Infection

MAVIRET® (glecaprevir/pibrentasvir) is now approved in the European Union for the treatment of acute hepatitis C virus (HCV)…
#Europe #EU #ABBV #AbbVie #European #nyse-abbv #pharmaceutical-investing
https://www.europesays.com/europe/77019/

https://www.europesays.com/news/43886/ US stocks drift after oil prices ease and Big Tech stocks fall #AbbVie #AmazonCom #ApogeeTherapeutics #BroadcomInc #Business #CMEGroup #EnergyMarkets #FederalReserveSystem #FinanceBusiness #FinancialMarkets #FinancialBusiness #GeneralNews #Headlines #Inc #Iran #IranWar #KeirStarmer #News #OilAndGasIndustry #SpaceX #StocksAndBonds #TopStories #WorldNews

https://www.europesays.com/iran/172547/ US stocks drift near their records after oil prices fall #AbbVie #ApogeeTherapeutics #Business #CMEGroup #EnergyMarkets #FederalReserveSystem #FinancialMarkets #GeneralNews #Inc #Iran #IranWar #KeirStarmer #OilAndGasIndustry #SpaceX #StocksAndBonds #WorldNews

US stocks drift near their records after oil prices fall

NEW YORK (AP) — U.S. stocks are drifting near their records in mixed trading Monday after trading resumed…
#NewsBeep #News #BreakingNews #AbbVie #ApogeeTherapeutics #breakingnews #Business #CMEGroup #energymarkets #FederalReserveSystem #financialmarkets #Generalnews #Inc. #Iran #iranwar #KeirStarmer #Oilandgasindustry #SpaceX #Stocksandbonds #Worldnews
https://www.newsbeep.com/605493/

US stocks drift near their records after oil prices fall

NEW YORK (AP) — U.S. stocks are drifting near their records in mixed trading Monday after trading resumed…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Business #AbbVie #ApogeeTherapeutics #CMEGroup #energymarkets #FederalReserveSystem #Financialmarkets #Generalnews #Inc. #iran #Iranwar #KeirStarmer #oilandgasindustry #spaceX #Stocksandbonds #Worldnews
https://www.newsbeep.com/us/719474/

US stocks drift near their records after oil prices fall

NEW YORK (AP) — U.S. stocks are drifting near their records in mixed trading Monday after trading resumed…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Business #AbbVie #ApogeeTherapeutics #CMEGroup #energymarkets #FederalReserveSystem #Financialmarkets #Generalnews #Inc. #iran #Iranwar #KeirStarmer #oilandgasindustry #spaceX #Stocksandbonds #Worldnews
https://www.newsbeep.com/us/719474/

US stocks drift near their records after oil prices fall

NEW YORK (AP) — U.S. stocks are drifting near their records in mixed trading Monday after trading resumed…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Business #AbbVie #ApogeeTherapeutics #CMEGroup #energymarkets #FederalReserveSystem #Financialmarkets #Generalnews #Inc. #iran #Iranwar #KeirStarmer #oilandgasindustry #spaceX #Stocksandbonds #Worldnews
https://www.newsbeep.com/us/719474/

3 Ridiculously Cheap Healthcare Stocks to Buy in June

Quick Read NVO sits 44% below its 52-week high with a price-to-free-cash-flow of 5 and a free cash…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #AbbVie #freecashflow #Health #HealthCareSelectSectorSPDRFund #NovoNordisk #nyse #operatingcashflow #top10AIstocks
https://www.newsbeep.com/us/702361/

3 Ridiculously Cheap Healthcare Stocks to Buy in June

Quick Read NVO sits 44% below its 52-week high with a price-to-free-cash-flow of 5 and a free cash…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #AbbVie #freecashflow #Health #HealthCareSelectSectorSPDRFund #NovoNordisk #nyse #operatingcashflow #top10AIstocks
https://www.newsbeep.com/us/702361/

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

Investors seeking reliable dividends and healthcare exposure often find themselves choosing between AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE). Both…
#NewsBeep #News #Healthcare #AbbVie #AU #Australia #currentratio #Health #Pfizer #shareholderequity
https://www.newsbeep.com/au/709601/

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

Investors seeking reliable dividends and healthcare exposure often find themselves choosing between AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE). Both…
#NewsBeep #News #Healthcare #AbbVie #AU #Australia #currentratio #Health #Pfizer #shareholderequity
https://www.newsbeep.com/au/709601/

https://www.europesays.com/uk/999494/ AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? #AbbVie #CurrentRatio #Health #Healthcare #Pfizer #ShareholderEquity #UK #UnitedKingdom

https://www.europesays.com/ie/513938/ AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? #AbbVie #CurrentRatio #Éire #Health #HealthCare #Healthcare #IE #Ireland #pfizer #ShareholderEquity

AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia

Addition of VENCLYXTO plus acalabrutinib, with or without obinutuzumab, and VENCLYXTO plus ibrutinib supported by data from Phase…
#Europe #EU #EuropeanCommission #ABBV #AbbVie #nyse-abbv #pharmaceutical-investing
https://www.europesays.com/europe/55761/

AbbVie: EC expands VENCLYXTO label in first-line CLL

Addition of VENCLYXTO plus acalabrutinib, with or without obinutuzumab, and VENCLYXTO plus ibrutinib supported by data from Phase…
#Europe #EU #ABBV #AbbVie #chroniclymphocyticleukemia #CLLtreatment #European #EuropeanCommission #labelexpansion #VENCLYXTO #venetoclax
https://www.europesays.com/europe/55608/

https://www.europesays.com/es/575239/ La migraña en mujeres, una enfermedad infravalorada | Ciencia es vida – ABBVIE #abbvie #Enfermedades #ES #España #Health #migraña #Mujeres #Neurología #PrevenciónEnfermedades #Salud #Spain

Analysis: Market Outlook for AbbVie Following Recent Earnings Performance

📰 Original title: Watch: Why Investors Are Still Worried About AbbVie

🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️

View full AI summary: https://killbait.com/en/analysis-market-outlook-for-abbvie-following-recent-earnings-performance/?redirpost=aefe28ea-2bb7-4a5d-86e4-14d8cd4103cd&utm_source=mastodon_world&utm_medium=social&utm_campaign=yOAxulYDJiR0231eonVH5fVZzdi42_IDdV5yvxQXYkQ

#business #abbvie #inves...

Analysis: Market Outlook for AbbVie Following Recent Earnings Performance

📰 Original title: Watch: Why Investors Are Still Worried About AbbVie

🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️

View full AI summary: https://killbait.com/en/analysis-market-outlook-for-abbvie-following-recent-earnings-performance/?redirpost=aefe28ea-2bb7-4a5d-86e4-14d8cd4103cd&utm_source=mastodon_world&utm_medium=social&utm_campaign=yOAxulYDJiR0231eonVH5fVZzdi42_IDdV5yvxQXYkQ

#business #abbvie #inves...

Analysis: Market Outlook for AbbVie Following Recent Earnings Performance

📰 Original title: Watch: Why Investors Are Still Worried About AbbVie

🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️

View full AI summary: https://killbait.com/en/analysis-market-outlook-for-abbvie-following-recent-earnings-performance/?redirpost=aefe28ea-2bb7-4a5d-86e4-14d8cd4103cd&utm_source=mastodon_social&utm_medium=social&utm_campaign=tawC1tPUo4nO8gfV507Ysi8dz02kz5dW5yXCkRHz8-k

#business #abbvie #inve...

Condamné à 850 000 €, le labo Abbvie paie (enfin) pour sa gestion opaque d’une pénurie critique. #medicament #AbbVie
https://www.lesmotsontunsens.com/penurie-de-medicaments-un-laboratoire-enfin-condamne/

Humira’s TrumpRx Discount Raises New Questions For AbbVie Valuation

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
#NewsBeep #News #Medication #AbbVie #AU #Australia #Health #Humira #individualinvestors #pricingdecision #whitehouse
https://www.newsbeep.com/au/594937/

Best Healthcare Stocks to Buy After the Market Pullback

Equity markets have moved in the wrong direction over the past three weeks. They may not rebound and…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #AbbVie #CVSHealth #geopoliticalissues #Health
https://www.newsbeep.com/us/535135/

Best Healthcare Stocks to Buy After the Market Pullback

Equity markets have moved in the wrong direction over the past three weeks. They may not rebound and…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #AbbVie #CVSHealth #geopoliticalissues #Health
https://www.newsbeep.com/us/535135/

https://www.europesays.com/ie/395313/ Best Healthcare Stocks to Buy After the Market Pullback #AbbVie #CVSHealth #Éire #GeopoliticalIssues #Health #HealthCare #Healthcare #IE #Ireland

https://www.europesays.com/es/455826/ Pacientes y familias aprenden a identificar cambios clave en la evolución del Parkinson #abbvie #Andalucía #aprenden #cambios #capacita #clave #clínico #desarrollan #detectar #enfermedad #entorno #ES #España #evolución #familiar #Familias #favorecer #fusan #Health #herramientas #identificar #Pacientes #parkinson #prácticas #proporciona #proyecto #Salud #seguimiento #Spain